Pfizer (PFE) Gross Profit (2009 - 2026)
Pfizer (PFE) posted quarterly Gross Profit of $10.9 billion for Q1 2026, little changed year-over-year from $10.9 billion in Q1 2025, and up 126.57% quarter-over-quarter from -$41.0 billion in Q4 2025.
Pfizer (PFE) Gross Profit (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Gross Profit for 18 consecutive years, with $10.9 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Gross Profit changed 0.3% year-over-year to $10.9 billion; the TTM figure through Mar 2026 stood at -$19.1 billion (down 130.09% YoY), while the FY2025 annual figure was -$6.8 billion, up 28.13% from the prior year.
- Gross Profit grew to $10.9 billion in Q1 2026 per PFE's latest filing, from -$41.0 billion in the prior quarter.
- Across five years, Gross Profit topped out at $33.9 billion in Q3 2024 and bottomed at -$41.0 billion in Q4 2025.
- Historically, Gross Profit has averaged $5.7 billion across 5 years, with a median of $10.9 billion in 2025.
- Annual changes were most pronounced in 2024 — Gross Profit surged 2799.6% — and 2025, when it slumped 120.52%.
- Pfizer's Gross Profit stood at $19.1 billion in 2022, then plunged by 121.62% to -$4.1 billion in 2023, then jumped by 921.55% to $33.9 billion in 2024, then tumbled by 220.95% to -$41.0 billion in 2025, then jumped by 126.57% to $10.9 billion in 2026.
- Business Quant data shows PFE's Gross Profit at $10.9 billion in Q1 2026, -$41.0 billion in Q4 2025, and $12.5 billion in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|